Buaboonnam J, Takpradit C, Viprakasit V, Narkbunnam N, Vathana N, Phuakpet K, et al. LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING. Mediterr J Hematol Infect Dis [Internet]. 2021 Oct. 29 [cited 2024 Apr. 18];13(1):e2021065. Available from: https://www.mjhid.org/mjhid/article/view/4720